Dr Reddy's Laboratories Q3 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01031
- Sector: Biotechnology & Drugs
BSE
1,157.35
-14.65 (-1.25%)
-14.65 (-1.25%)Volume2.78 L
Updated: Mon 10 Aug, 2026 | 15:51:52
NSE
1,158.80-13.20 (-1.13%)
-13.20 (-1.13%)Volume1.77 M
Updated: Mon 10 Aug, 2026 | 15:14:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Dr Reddy's Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 7,386.90 | 6,358.70 | 0.87% | 6,579.60 | 12.27% |
| Depreciation/ Amortization | 521.00 | 397.00 | 3.25% | 471.40 | 10.52% |
| Operating Income | 1,366.50 | 1,679.50 | -9.22% | 1,801.60 | -24.15% |
| Net Income | 1,209.90 | 1,255.70 | -10.18% | 1,413.70 | -14.42% |
| Other Operating Expenses Total | 2,155.10 | - | -0.93% | - | N/A |
| Net Income Before Taxes | 1,543.20 | 1,917.40 | -11.55% | 1,874.30 | -17.67% |
| Total Revenue | 8,753.40 | 8,038.20 | -0.85% | 8,381.20 | 4.44% |
| Selling/ General/ Admin Expenses Total | 1,588.50 | 3,502.60 | 9.39% | 3,527.10 | -54.96% |
| Diluted Normalized EPS | 14.77 | 15.85 | -12.03% | 16.94 | -12.79% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.